METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis

Table 1

Correlation between clinicopathologic parameters and expression level of METTL16.

Clinicopathological parameters	METTL16 expression level
	High (4)	Low (26)	P-value
Age (years)
<50	3	14
≥50	1	12	0.6129
FIGO stage
Ⅰ + Ⅱ	4	4
Ⅲ + Ⅳ	0	22
Tumor size (cm)
<5	4	3
≥5	0	23
Lymph node metastasis
Yes	1	23
No	3	3
Grade
G1	2	7
G2 + G3	2	19	0.5632

; .